Janux Therapeutics, Inc. (JANX)
NASDAQ·Healthcare·Biotechnology
$14.44
-5.22%
Mkt Cap $924.03M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $83.33K | $7.88M | +9356.04% | -$0.65 | -$0.51 | +21.54% | — | — |
| Q4 2025 Nov 6, 2025 | — | $10.00M | — | -$0.60 | -$0.39 | +35.00% | — | — |
| Q3 2025 Aug 7, 2025 | $300.00K | — | — | -$0.48 | -$0.55 | -14.58% | — | — |
| Q2 2025 May 8, 2025 | $660.00K | — | — | -$0.43 | -$0.38 | +11.63% | — | — |
| Q1 2025 Feb 27, 2025 | $1.82M | — | — | -$0.49 | -$0.36 | +26.53% | — | — |
| Q4 2024 Nov 6, 2024 | $1.50M | $439.00K | -70.64% | -$0.37 | -$0.51 | -37.84% | — | — |
| Q3 2024 Aug 7, 2024 | $1.45M | $8.90M | +513.59% | -$0.32 | -$0.11 | +65.63% | — | — |
| Q2 2024 May 7, 2024 | $660.00K | $1.25M | +89.70% | -$0.35 | -$0.30 | +14.29% | — | — |
| Q1 2024 Mar 8, 2024 | $740.00K | $2.46M | +232.57% | -$0.37 | -$0.25 | +32.43% | — | — |
| Q4 2023 Nov 7, 2023 | $590.00K | $2.52M | +326.61% | -$0.46 | -$0.25 | +45.65% | — | — |
| Q3 2023 Aug 8, 2023 | $875.00K | $1.06M | +20.80% | -$0.52 | -$0.42 | +19.23% | — | — |
| Q2 2023 May 9, 2023 | $870.00K | $2.05M | +135.40% | -$0.49 | -$0.42 | +14.29% | — | — |
| Q1 2023 Mar 10, 2023 | $670.00K | $2.85M | +324.63% | -$0.45 | -$0.39 | +13.33% | — | — |
| Q4 2022 Nov 10, 2022 | $790.00K | $1.81M | +129.49% | -$0.51 | -$0.40 | +21.57% | — | — |
| Q3 2022 Aug 9, 2022 | $650.00K | $2.37M | +263.85% | -$0.37 | -$0.41 | -10.81% | — | — |
| Q2 2022 May 10, 2022 | $810.40K | $1.59M | +96.08% | -$0.37 | -$0.32 | +13.51% | — | — |
| Q1 2022 Mar 18, 2022 | $433.33K | $1.62M | +272.92% | -$0.30 | -$0.33 | -10.00% | — | — |
| Q4 2021 Nov 9, 2021 | $130.00K | $1.16M | +791.54% | -$0.17 | -$0.26 | -52.94% | — | — |
| Q3 2021 Aug 10, 2021 | $482.00K | $482.00K | +0.00% | -$0.13 | -$0.62 | -376.92% | — | — |
| Q2 2021 Jun 11, 2021 | — | — | — | — | -$0.13 | — | — | — |